Genetic Markers
Biological Markers
Microsatellite Repeats
Chromosome Mapping
Genotype
Genetic Linkage
Alleles
Polymorphism, Single Nucleotide
Polymorphism, Genetic
Tumor Markers, Biological
Models, Genetic
Sequence Analysis, DNA
Polymerase Chain Reaction
Gene Frequency
Haplotypes
Genetics, Population
Phenotype
Polymorphism, Restriction Fragment Length
Genetic Predisposition to Disease
Crosses, Genetic
Base Sequence
Molecular Sequence Data
Linkage Disequilibrium
Recombination, Genetic
Pedigree
Physical Chromosome Mapping
Genome-Wide Association Study
DNA Primers
HLA-B15 Antigen
Expressed Sequence Tags
Quantitative Trait, Heritable
DNA, Mitochondrial
Case-Control Studies
Mutation
Species Specificity
Resedaceae
Breeding
Hybridization, Genetic
Genetic Loci
Lod Score
Heterozygote
Amplified Fragment Length Polymorphism Analysis
Geography
Dinucleotide Repeats
Algorithms
Phylogeography
Likelihood Functions
Bayes Theorem
Random Amplified Polymorphic DNA Technique
Gene Flow
Chromosomes, Artificial, Bacterial
Minisatellite Repeats
Sequence Tagged Sites
Contig Mapping
Tandem Repeat Sequences
Cattle
Transformation, Genetic
Cluster Analysis
Genome
Blood Group Antigens
Genome, Human
Prognosis
Models, Statistical
Genetic Diseases, Inborn
Chromosomes, Bacterial
Chromosomes, Plant
Genetic Association Studies
Genes, Dominant
Computer Simulation
DNA
Gene Expression Profiling
Immunohistochemistry
Genotyping Techniques
Vaccines, Marker
Immunoglobulin Gm Allotypes
Sensitivity and Specificity
DNA Fingerprinting
Evolution, Molecular
Software
INDEL Mutation
Genes
Genetic Testing
Bacteroidetes
Risk Factors
Molecular Epidemiology
Selection, Genetic
HLA Antigens
Cell Differentiation
Immunoglobulin Allotypes
Digitalis
DNA Transposable Elements
Reproducibility of Results
Repetitive Sequences, Nucleic Acid
Genetics
Oligonucleotide Array Sequence Analysis
Hybrid Cells
Pharmacogenetics
DNA, Satellite
European Continental Ancestry Group
Cloning, Molecular
Oncorhynchus
Predictive Value of Tests
DNA, Ribosomal
Rh-Hr Blood-Group System
Asian Continental Ancestry Group
Blotting, Southern
Gene Library
Computational Biology
Molecular Biology
Chromosomes, Human, Pair 1
Chromosomes
Reverse Transcriptase Polymerase Chain Reaction
Crossing Over, Genetic
Nucleic Acid Hybridization
Nidovirales
Hip Dysplasia, Canine
Forensic Genetics
DNA Restriction Enzymes
Restriction Mapping
In Situ Hybridization, Fluorescence
Gene Pool
Diploidy
RNA, Messenger
Feces
Nuchal Cord
Amino Acid Sequence
Animals, Domestic
Y Chromosome
DNA, Ribosomal Spacer
Azaguanine
Drug Resistance
Epistasis, Genetic
Genetic Techniques
Sequence Alignment
Genes, Mitochondrial
Genetics, Microbial
Data Interpretation, Statistical
Oryza sativa
Deoxyribonucleases, Type II Site-Specific
Plasmodium vivax
HLA-DQ Antigens
Bacterial Typing Techniques
Immunoglobulin Km Allotypes
HLA-DR Antigens
Cells, Cultured
Immunogenetics
Chromosomes, Human, Pair 8
Chromosome Aberrations
Genomic Library
HLA-B Antigens
Chromosomes, Human, Pair 16
Gene Expression
Chromosomes, Human, Y
Real-Time Polymerase Chain Reaction
DNA Probes
Chromosomes, Human
Mice, Inbred Strains
Chromosomes, Human, Pair 6
Plasmids
Chromosomes, Human, Pair 7
Disease Susceptibility
Chromosomes, Human, Pair 11
Transcriptome
Principal Component Analysis
User-Computer Interface
Streptomycin
11q23.1 and 11q25-qter YACs suppress tumour growth in vivo. (1/12529)
Frequent allelic deletion at chromosome 11q22-q23.1 has been described in breast cancer and a number of other malignancies, suggesting putative tumour suppressor gene(s) within the approximately 8 Mb deleted region. In addition, we recently described another locus, at the 11q25-qter region, frequently deleted in breast cancer, suggesting additional tumour suppressor gene(s) in this approximately 2 Mb deleted region. An 11q YAC contig was accessed and three YACs, one containing the candidate gene ATM at 11q23.1, and two contiguous YACs (overlapping for approximately 400-600 kb) overlying most of the 11q25 deleted region, were retrofitted with a G418 resistance marker and transfected into murine A9 fibrosarcoma cells. Selected A9 transfectant clones (and control untransfected and 'irrelevant' alphoid YAC transfectant A9 clones) were assayed for in vivo tumorigenicity in athymic female Balb c-nu/nu mice. All the 11q YAC transfectant clones demonstrated significant tumour suppression compared to the control untransfected and 'irrelevant' YAC transfected A9 cells. These results define two discrete tumour suppressor loci on chromosome 11q by functional complementation, one to a approximately 1.2 Mb region on 11q23.1 (containing the ATM locus) and another to a approximately 400-600 kb subterminal region on 11q25-qter. (+info)Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer. (2/12529)
The evolution of alterations on chromosome 9, including the putative tumor suppressor genes mapped to the 9p21-22 region (the MTS genes), was studied in relation to the progression of human urinary bladder neoplasia by using whole organ superimposed histologic and genetic mapping in cystectomy specimens and was verified in urinary bladder tumors of various pathogenetic subsets with longterm follow-up. The applicability of chromosome 9 allelic losses as non-invasive markers of urothelial neoplasia was tested on voided urine and/or bladder washings of patients with urinary bladder cancer. Although sequential multiple hits in the MTS locus were documented in the development of intraurothelial precursor lesions, the MTS genes do not seem to represent a major target for p21-23 deletions in bladder cancer. Two additional tumor suppressor genes involved in bladder neoplasia located distally and proximally to the MTS locus within p22-23 and p11-13 regions respectively were identified. Several distinct putative tumor suppressor gene loci within the q12-13, q21-22, and q34 regions were identified on the q arm. In particular, the pericentromeric q12-13 area may contain the critical tumor suppressor gene or genes for the development of early urothelial neoplasia. Allelic losses of chromosome 9 were associated with expansion of the abnormal urothelial clone which frequently involved large areas of urinary bladder mucosa. These losses could be found in a high proportion of urothelial tumors and in voided urine or bladder washing samples of nearly all patients with urinary bladder carcinoma. (+info)Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer. (3/12529)
Twelve Barrett's adenocarcinomas have been analysed for the occurrence of allelic imbalance (LOH) on chromosome 17 using 41 microsatellite markers. This study provides evidence for 13 minimal regions of LOH, six on 17p and seven on 17q. Four of these centre in the vicinity of the known tumour suppressor genes (TSGs) TP53 (17p13.1), NFI (17q11.2), BRCA1 (17q21.1), and a putative TSG (17p13.3). The tumours all displayed relatively small regions of LOH (1-10 cM), and in several tumours extensive regions of LOH were detected. One tumour displayed only two very small regions of LOH; 17p11.2 and 17p13.1. The frequency of allelic imbalance has been calculated based on the LOH encompassing only one minimal region, and based on all the LOH observations. By both evaluations the highest LOH frequencies were found for regions II (p53), III (17p13.1 centromeric to p53), IV (17p12), V (17p11.2) and VII (NF1, 17q11.2). Our data supports the existence of multiple TSGs on chromosome 17 and challenges the view that p53 is the sole target of LOH on 17p in Barrett's adenocarcinoma. (+info)Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma. (4/12529)
The association of p53 abnormalities with the prognosis of patients with non-small cell lung carcinoma (NSCLC) has been extensively investigated to date, however, this association is still controversial. Therefore, we investigated the prognostic significance of p53 mutations through exons 2 to 11 and p53 protein expression in 103 cases of stage I NSCLC. p53 mutations were detected in 49 of 103 (48%) tumors. Two separate mutations were detected in four tumors giving a total of 53 unique mutations in 49 tumors. Ten (19%) of mutations occurred outside exons 5-8. Positive immunohistochemical staining of p53 protein was detected in 41 of 103 (40%) tumors. The concordance rate between mutations and protein overexpression was only 69%. p53 mutations, but not expression, were significantly associated with a shortened survival of patients (P<0.001). Furthermore, we investigated the correlation between the types of p53 mutations and prognosis. p53 missense mutations rather than null mutations were associated with poor prognosis (P < 0.001 in missense mutations and P=0.243 in null mutations). These results indicated that p53 mutations, in particular missense mutations, rather than p53 expression could be a useful molecular marker for the prognosis of patients with surgically resected stage I NSCLC. (+info)p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. (5/12529)
p73, a novel p53 family member, is a recently identified candidate neuroblastoma (NBL) suppressor gene mapped at chromosome 1p36.33 and was found to inhibit growth and induce apoptosis in cell lines. To test the hypothesis that p73 is a NBL suppressor gene, we analysed the p73 gene in primary human NBLs. Loss of heterozygosity (LOH) for p73 was observed in 19% (28/151) of informative cases which included 92 mass-screening (MS) tumors. The high frequency of p73 LOH was significantly associated with sporadic NBLs (9% vs 34%, P<0.001), N-myc amplification (10% vs 71%, P<0.001), and advanced stage (14% vs 28%, P<0.05). Both p73alpha and p73beta transcripts were detectable in only 46 of 134 (34%) NBLs at low levels by RT-PCR methods, while they were easily detectable in most breast cancers and colorectal cancers under the same conditions. They found no correlation between p73 LOH and its expression levels (P>0.1). We found two mutations out of 140 NBLs, one somatic and one germline, which result in amino acid substitutions in the C-terminal region of p73 which may affect transactivation functions, though, in the same tumor samples, no mutation of the p53 gene was observed as reported previously. These results suggest that allelic loss of the p73 gene may be a later event in NBL tumorigenesis. However, p73 is infrequently mutated in primary NBLs and may hardly function as a tumor suppressor in a classic Knudson's manner. (+info)High polymorphism level of genomic sequences flanking insertion sites of human endogenous retroviral long terminal repeats. (6/12529)
The polymorphism at the multitude of loci adjacent to human endogenous retrovirus long terminal repeats (LTRs) was analyzed by a technique for whole genome differential display based on the PCR suppression effect that provides selective amplification and display of genomic sequences flanking interspersed repeated elements. This strategy is simple, target-specific, requires a small amount of DNA and provides reproducible and highly informative data. The average frequency of polymorphism observed in the vicinity of the LTR insertion sites was found to be about 12%. The high incidence of polymorphism within the LTR flanks together with the frequent location of LTRs near genes makes the LTR loci a useful source of polymorphic markers for gene mapping. (+info)Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. (7/12529)
BACKGROUND: cag pathogenicity island (PAI) is reported to be a major virulence factor of Helicobacter pylori. AIM: To characterise cagA and the cag PAI in Japanese H pylori strains. METHODS: H pylori isolates from Japanese patients were evaluated for CagA by immunoblot, for cagA transcription by northern blot, and for cagA and 13 other cag PAI genes by Southern blot. cagA negative strains from Western countries were also studied. Induction of interleukin-8 secretion from gastric epithelial cells was also investigated. RESULTS: All Japanese strains retained cagA. Fifty nine of 63 (94%) strains had all the cag PAI genes. In the remaining four, cag PAI was partially deleted, lacking cagA transcripts and not producing CagA protein. Details of the PAI of these strains were checked; three lacked cagB to cagQ (cagI) and continuously cagS to cag13 (cagII), and the remaining one lacked cagB to cag8. Western cagA negative strains completely lacked cag PAI including cagA. Nucleotide sequence analysis in one strain in which the cag PAI was partially deleted showed that the partial deletion contained 25 kb of cag PAI and the cagA promoter. Interleukin-8 induction was lower with the cag PAI partial deletion strains than with the intact ones. All Japanese cag PAI deleted strains were derived from patients with non-ulcer dyspepsia, whereas 41 of 59 (70%) CagA-producing strains were from patients with peptic ulcers or gastric cancer (p<0.05). CONCLUSIONS: Most Japanese H pylori strains had the intact cag PAI. However, some lacked most of the cag PAI in spite of the presence of cagA. Thus the presence of the cagA gene is not an invariable marker of cag PAI related virulence in Japanese strains. (+info)Screening for mutations of the cationic trypsinogen gene: are they of relevance in chronic alcoholic pancreatitis? (8/12529)
BACKGROUND: In hereditary pancreatitis mutations of exons 2 (N21I) and 3 (R117H) of the cationic trypsinogen gene have been described. AIMS: To investigate whether the same mutations can also be found in patients with chronic alcoholic pancreatitis. METHODS: Leucocyte DNA was prepared from 23 patients with chronic alcoholic pancreatitis, 21 with alcoholic liver cirrhosis, 34 individuals from seven independent families with hereditary pancreatitis, and 15 healthy controls. DNA was also obtained from pancreatic tissue (n=7) and from pancreatic juice (n=5) of patients suffering from chronic alcoholic pancreatitis. R117H was detected by restriction digestion with Afl III. N21I was identified by an allele specific polymerase chain reaction (PCR). RESULTS: R117H was detected in four families with hereditary pancreatitis. The N21I mutation was identified in three families. All mutations were confirmed by sequencing of the corresponding DNAs. In patients with chronic alcoholic pancreatitis neither the exon 2 nor exon 3 mutations were present in blood leucocytes, pancreatic juice, or pancreatic tissue. DNA of the patients with alcoholic liver cirrhosis as well as all controls was of wild type. CONCLUSIONS: The allele specific PCR may be used to screen for the N21I mutation of cationic trypsinogen. Both trypsinogen mutations were found in hereditary pancreatitis but do not seem to be major pathogenic factors in chronic alcoholic pancreatitis. (+info)Explanation: Genetic predisposition to disease is influenced by multiple factors, including the presence of inherited genetic mutations or variations, environmental factors, and lifestyle choices. The likelihood of developing a particular disease can be increased by inherited genetic mutations that affect the functioning of specific genes or biological pathways. For example, inherited mutations in the BRCA1 and BRCA2 genes increase the risk of developing breast and ovarian cancer.
The expression of genetic predisposition to disease can vary widely, and not all individuals with a genetic predisposition will develop the disease. Additionally, many factors can influence the likelihood of developing a particular disease, such as environmental exposures, lifestyle choices, and other health conditions.
Inheritance patterns: Genetic predisposition to disease can be inherited in an autosomal dominant, autosomal recessive, or multifactorial pattern, depending on the specific disease and the genetic mutations involved. Autosomal dominant inheritance means that a single copy of the mutated gene is enough to cause the disease, while autosomal recessive inheritance requires two copies of the mutated gene. Multifactorial inheritance involves multiple genes and environmental factors contributing to the development of the disease.
Examples of diseases with a known genetic predisposition:
1. Huntington's disease: An autosomal dominant disorder caused by an expansion of a CAG repeat in the Huntingtin gene, leading to progressive neurodegeneration and cognitive decline.
2. Cystic fibrosis: An autosomal recessive disorder caused by mutations in the CFTR gene, leading to respiratory and digestive problems.
3. BRCA1/2-related breast and ovarian cancer: An inherited increased risk of developing breast and ovarian cancer due to mutations in the BRCA1 or BRCA2 genes.
4. Sickle cell anemia: An autosomal recessive disorder caused by a point mutation in the HBB gene, leading to defective hemoglobin production and red blood cell sickling.
5. Type 1 diabetes: An autoimmune disease caused by a combination of genetic and environmental factors, including multiple genes in the HLA complex.
Understanding the genetic basis of disease can help with early detection, prevention, and treatment. For example, genetic testing can identify individuals who are at risk for certain diseases, allowing for earlier intervention and preventive measures. Additionally, understanding the genetic basis of a disease can inform the development of targeted therapies and personalized medicine."
These disorders are caused by changes in specific genes that fail to function properly, leading to a cascade of effects that can damage cells and tissues throughout the body. Some inherited diseases are the result of single gene mutations, while others are caused by multiple genetic changes.
Inherited diseases can be diagnosed through various methods, including:
1. Genetic testing: This involves analyzing a person's DNA to identify specific genetic changes that may be causing the disease.
2. Blood tests: These can help identify certain inherited diseases by measuring enzyme levels or identifying specific proteins in the blood.
3. Imaging studies: X-rays, CT scans, and MRI scans can help identify structural changes in the body that may be indicative of an inherited disease.
4. Physical examination: A healthcare provider may perform a physical examination to look for signs of an inherited disease, such as unusual physical features or abnormalities.
Inherited diseases can be treated in various ways, depending on the specific condition and its causes. Some treatments include:
1. Medications: These can help manage symptoms and slow the progression of the disease.
2. Surgery: In some cases, surgery may be necessary to correct physical abnormalities or repair damaged tissues.
3. Gene therapy: This involves using genes to treat or prevent inherited diseases.
4. Rehabilitation: Physical therapy, occupational therapy, and other forms of rehabilitation can help individuals with inherited diseases manage their symptoms and improve their quality of life.
Inherited diseases are a significant public health concern, as they affect millions of people worldwide. However, advances in genetic research and medical technology have led to the development of new treatments and management strategies for these conditions. By working with healthcare providers and advocacy groups, individuals with inherited diseases can access the resources and support they need to manage their conditions and improve their quality of life.
The hip joint is a ball-and-socket joint that connects the thigh bone (femur) to the pelvis. In a normal hip joint, the ball (the head of the femur) fits snugly into the socket (the acetabulum). However, in dogs with hip dysplasia, the ball and socket may not fit together properly, causing the joint to become loose or unstable. This can lead to inflammation, pain, and degenerative changes in the joint over time.
There are two main types of hip dysplasia in dogs: developmental hip dysplasia and degenerative hip dysplasia. Developmental hip dysplasia occurs when the hip joint does not form properly during fetal development, while degenerative hip dysplasia is caused by wear and tear on the joint over time.
The symptoms of hip dysplasia in dogs can vary depending on the severity of the condition, but may include:
* Lameness or difficulty walking
* Pain or discomfort
* Stiffness or limited mobility
* Difficulty rising or climbing stairs
* Decreased activity level or reluctance to exercise
* Grinding or clicking sounds when the dog moves its hip joint
Hip dysplasia is typically diagnosed through a combination of physical examination, radiographs (x-rays), and arthroscopy. Treatment options for the condition may include:
* Medication to manage pain and inflammation
* Weight management to reduce the strain on the joint
* Surgery to repair or replace the damaged joint
* Physical therapy to improve mobility and strength
Preventative measures such as feeding a balanced diet, providing plenty of exercise and weight management can help to reduce the risk of developing hip dysplasia in dogs. However, if the condition does occur, early diagnosis and treatment can help to manage the symptoms and improve the dog's quality of life.
Example sentence: "The nuchal cord was detected during an ultrasound examination, and further monitoring was recommended to ensure the health and well-being of the fetus."
There are several types of chromosome aberrations, including:
1. Chromosomal deletions: Loss of a portion of a chromosome.
2. Chromosomal duplications: Extra copies of a chromosome or a portion of a chromosome.
3. Chromosomal translocations: A change in the position of a chromosome or a portion of a chromosome.
4. Chromosomal inversions: A reversal of a segment of a chromosome.
5. Chromosomal amplifications: An increase in the number of copies of a particular chromosome or gene.
Chromosome aberrations can be detected through various techniques, such as karyotyping, fluorescence in situ hybridization (FISH), or array comparative genomic hybridization (aCGH). These tests can help identify changes in the chromosomal makeup of cells and provide information about the underlying genetic causes of disease.
Chromosome aberrations are associated with a wide range of diseases, including:
1. Cancer: Chromosome abnormalities are common in cancer cells and can contribute to the development and progression of cancer.
2. Birth defects: Many birth defects are caused by chromosome abnormalities, such as Down syndrome (trisomy 21), which is caused by an extra copy of chromosome 21.
3. Neurological disorders: Chromosome aberrations have been linked to various neurological disorders, including autism and intellectual disability.
4. Immunodeficiency diseases: Some immunodeficiency diseases, such as X-linked severe combined immunodeficiency (SCID), are caused by chromosome abnormalities.
5. Infectious diseases: Chromosome aberrations can increase the risk of infection with certain viruses, such as human immunodeficiency virus (HIV).
6. Ageing: Chromosome aberrations have been linked to the ageing process and may contribute to the development of age-related diseases.
7. Radiation exposure: Exposure to radiation can cause chromosome abnormalities, which can increase the risk of cancer and other diseases.
8. Genetic disorders: Many genetic disorders are caused by chromosome aberrations, such as Turner syndrome (45,X), which is caused by a missing X chromosome.
9. Rare diseases: Chromosome aberrations can cause rare diseases, such as Klinefelter syndrome (47,XXY), which is caused by an extra copy of the X chromosome.
10. Infertility: Chromosome abnormalities can contribute to infertility in both men and women.
Understanding the causes and consequences of chromosome aberrations is important for developing effective treatments and improving human health.
Malignant prostatic neoplasms are cancerous tumors that can be aggressive and spread to other parts of the body (metastasize). The most common type of malignant prostatic neoplasm is adenocarcinoma of the prostate, which accounts for approximately 95% of all prostate cancers. Other types of malignant prostatic neoplasms include sarcomas and small cell carcinomas.
Prostatic neoplasms can be diagnosed through a variety of tests such as digital rectal examination (DRE), prostate-specific antigen (PSA) test, imaging studies (ultrasound, CT scan or MRI), and biopsy. Treatment options for prostatic neoplasms depend on the type, stage, and grade of the tumor, as well as the patient's age and overall health. Treatment options can include active surveillance, surgery (robotic-assisted laparoscopic prostatectomy or open prostatectomy), radiation therapy (external beam radiation therapy or brachytherapy), and hormone therapy.
In summary, Prostatic Neoplasms are tumors that occur in the prostate gland, which can be benign or malignant. The most common types of malignant prostatic neoplasms are adenocarcinoma of the prostate, and other types include sarcomas and small cell carcinomas. Diagnosis is done through a variety of tests, and treatment options depend on the type, stage, and grade of the tumor, as well as the patient's age and overall health.
There are different types of Breast Neoplasms such as:
1. Fibroadenomas: These are benign tumors that are made up of glandular and fibrous tissues. They are usually small and round, with a smooth surface, and can be moved easily under the skin.
2. Cysts: These are fluid-filled sacs that can develop in both breast tissue and milk ducts. They are usually benign and can disappear on their own or be drained surgically.
3. Ductal Carcinoma In Situ (DCIS): This is a precancerous condition where abnormal cells grow inside the milk ducts. If left untreated, it can progress to invasive breast cancer.
4. Invasive Ductal Carcinoma (IDC): This is the most common type of breast cancer and starts in the milk ducts but grows out of them and invades surrounding tissue.
5. Invasive Lobular Carcinoma (ILC): It originates in the milk-producing glands (lobules) and grows out of them, invading nearby tissue.
Breast Neoplasms can cause various symptoms such as a lump or thickening in the breast or underarm area, skin changes like redness or dimpling, change in size or shape of one or both breasts, discharge from the nipple, and changes in the texture or color of the skin.
Treatment options for Breast Neoplasms may include surgery such as lumpectomy, mastectomy, or breast-conserving surgery, radiation therapy which uses high-energy beams to kill cancer cells, chemotherapy using drugs to kill cancer cells, targeted therapy which uses drugs or other substances to identify and attack cancer cells while minimizing harm to normal cells, hormone therapy, immunotherapy, and clinical trials.
It is important to note that not all Breast Neoplasms are cancerous; some are benign (non-cancerous) tumors that do not spread or grow.
There are several types of disease susceptibility, including:
1. Genetic predisposition: This refers to the inherent tendency of an individual to develop a particular disease due to their genetic makeup. For example, some families may have a higher risk of developing certain diseases such as cancer or heart disease due to inherited genetic mutations.
2. Environmental susceptibility: This refers to the increased risk of developing a disease due to exposure to environmental factors such as pollutants, toxins, or infectious agents. For example, someone who lives in an area with high levels of air pollution may be more susceptible to developing respiratory problems.
3. Lifestyle susceptibility: This refers to the increased risk of developing a disease due to unhealthy lifestyle choices such as smoking, lack of exercise, or poor diet. For example, someone who smokes and is overweight may be more susceptible to developing heart disease or lung cancer.
4. Immune system susceptibility: This refers to the increased risk of developing a disease due to an impaired immune system. For example, people with autoimmune disorders such as HIV/AIDS or rheumatoid arthritis may be more susceptible to opportunistic infections.
Understanding disease susceptibility can help healthcare providers identify individuals who are at risk of developing certain diseases and provide preventive measures or early intervention to reduce the risk of disease progression. Additionally, genetic testing can help identify individuals with a high risk of developing certain diseases, allowing for earlier diagnosis and treatment.
In summary, disease susceptibility refers to the predisposition of an individual to develop a particular disease or condition due to various factors such as genetics, environment, lifestyle choices, and immune system function. Understanding disease susceptibility can help healthcare providers identify individuals at risk and provide appropriate preventive measures or early intervention to reduce the risk of disease progression.
Vivax malaria is characterized by a more gradual onset of symptoms compared to other types of malaria, such as Plasmodium falciparum. The symptoms of vivax malaria can include fever, chills, headache, muscle and joint pain, fatigue, nausea, vomiting, and diarrhea. In severe cases, it can lead to anemia, kidney failure, seizures, coma, and death.
Vivax malaria is typically diagnosed through a physical examination, medical history, and laboratory tests such as blood smears or PCR (polymerase chain reaction) tests. Treatment for vivax malaria typically involves the use of antimalarial drugs, such as chloroquine or primaquine, which are effective against the parasite but not against other types of malaria.
Prevention is key to avoiding malaria, and this includes taking antimalarial medications before traveling to areas where malaria is common, wearing protective clothing and applying insect repellent to prevent mosquito bites, and using bed nets that have been treated with insecticide. Eliminating standing water around homes and communities can also help reduce the number of mosquitoes and the risk of malaria.
In conclusion, vivax malaria is a serious and sometimes life-threatening disease caused by a parasite that is transmitted through the bite of an infected mosquito. It is important to be aware of the risk of malaria when traveling to areas where it is common, and to take preventive measures such as using antimalarial medications and protective clothing to avoid infection.
Disease progression can be classified into several types based on the pattern of worsening:
1. Chronic progressive disease: In this type, the disease worsens steadily over time, with a gradual increase in symptoms and decline in function. Examples include rheumatoid arthritis, osteoarthritis, and Parkinson's disease.
2. Acute progressive disease: This type of disease worsens rapidly over a short period, often followed by periods of stability. Examples include sepsis, acute myocardial infarction (heart attack), and stroke.
3. Cyclical disease: In this type, the disease follows a cycle of worsening and improvement, with periodic exacerbations and remissions. Examples include multiple sclerosis, lupus, and rheumatoid arthritis.
4. Recurrent disease: This type is characterized by episodes of worsening followed by periods of recovery. Examples include migraine headaches, asthma, and appendicitis.
5. Catastrophic disease: In this type, the disease progresses rapidly and unpredictably, with a poor prognosis. Examples include cancer, AIDS, and organ failure.
Disease progression can be influenced by various factors, including:
1. Genetics: Some diseases are inherited and may have a predetermined course of progression.
2. Lifestyle: Factors such as smoking, lack of exercise, and poor diet can contribute to disease progression.
3. Environmental factors: Exposure to toxins, allergens, and other environmental stressors can influence disease progression.
4. Medical treatment: The effectiveness of medical treatment can impact disease progression, either by slowing or halting the disease process or by causing unintended side effects.
5. Co-morbidities: The presence of multiple diseases or conditions can interact and affect each other's progression.
Understanding the type and factors influencing disease progression is essential for developing effective treatment plans and improving patient outcomes.
Some common effects of chromosomal deletions include:
1. Genetic disorders: Chromosomal deletions can lead to a variety of genetic disorders, such as Down syndrome, which is caused by a deletion of a portion of chromosome 21. Other examples include Prader-Willi syndrome (deletion of chromosome 15), and Williams syndrome (deletion of chromosome 7).
2. Birth defects: Chromosomal deletions can increase the risk of birth defects, such as heart defects, cleft palate, and limb abnormalities.
3. Developmental delays: Children with chromosomal deletions may experience developmental delays, learning disabilities, and intellectual disability.
4. Increased cancer risk: Some chromosomal deletions can increase the risk of developing certain types of cancer, such as chronic myelogenous leukemia (CML) and breast cancer.
5. Reproductive problems: Chromosomal deletions can lead to reproductive problems, such as infertility or recurrent miscarriage.
Chromosomal deletions can be diagnosed through a variety of techniques, including karyotyping (examination of the chromosomes), fluorescence in situ hybridization (FISH), and microarray analysis. Treatment options for chromosomal deletions depend on the specific effects of the deletion and may include medication, surgery, or other forms of therapy.
Genetic marker
Thoroughbred breeding theories
Thoroughbred
Two layer hypothesis
Antonio Arnaiz-Villena
Sequence-related amplified polymorphism
WormBase
Psychiatric genetics
Restriction site associated DNA markers
Y-chromosomal Aaron
Axial Biotech
Supertaster
Diego antigen system
Khazar hypothesis of Ashkenazi ancestry
Matrilineality in Judaism
Ancestry-informative marker
The Gene: An Intimate History
Finnish heritage disease
Wheat
Hubert Walter (anthropologist)
Triple-negative breast cancer
2013 in the United States
Atayal people
2013 in science
Pentro horse
Mycocepurus smithii
Stanley Michael Gartler
Robin Haring
Philip Holzman
Population structure (genetics)
Avena byzantina
Cervical cancer
Obstetric ultrasonography
Switch-reference
Pretendian
Kristine Kochanski
Papillary carcinomas of the breast
CLINT1
Sam Beckett
Halobacterium salinarum
Asymmetric crying facies
Water deer
Herbert Boyer
Sulfolobus
MiR-137
League of Assassins
RK2 plasmid
Southwestern Native Aquatic Resources and Recovery Center
Prunus × nudiflora
Mitochondrial DNA
Paul J. Turek
Zinc deficiency
Cofán language
Genetic studies on Serbs
Predictive medicine
Paleolithic
List of Metal Gear characters
Taiwanese people
Sexual selection
Rhubarb
Genetic analysis of 18 X-linked short tandem repeat markers in Korean population
Browsing Technical Documents by Subject "Genetic Markers"
Genetic Markers for COVID Spread Confound Medical Experts - The National Center
Genetic evaluation of Spanish and Nigerian chickens using,microsatellite markers
Genetic characterization of oleaginous bottle gourd (Lagenaria siceraria) germplasm from Côte d'Ivoire using agromorphological...
Genetic Markers Enhance Coronary Risk Prediction in Men: The MORGAM Prospective Cohorts
Genetic Markers - English
You Can Test Your Pup's DNA For Genetic Markers With A $95 Orivet DNA Kit | IFLScience
The pdx genetic marker adjacent to the chloramphenicol biosynthesis gene cluster in Streptomyces venezuelae ISP5230: functional...
Risk Factors for Coronary Artery Disease: Practice Essentials, Risk Factor Biomarkers, Conventional Risk Factors
Results of search for 'su:{Genetic markers}'
›
WHO HQ Library catalog
NEW STUDY REVEALS SHARED GENETIC MARKERS UNDERLYING SUBSTANCE USE DISORDERS
Key diagnostic markers for autoimmune lymphoproliferative syndrome with molecular genetic diagnosis. | Blood;136(17): 1933...
EN
View of Potential of Microsatellites Markers for the Genetic Analysis of Bryophytes
Detection of intrapopulation genetic variation of leptinotarsa decemlineata (say) using issr-markers and phenoforms
Men's Testosterone Levels Are Determined by Where They Grow Up, Research Finds | Everyday Health
CMU Intellectual Repository: Molecular Identification, Genetic Relationships and Development of DNA Markers of Spirogyra spp.
Community Mitigation Guidelines to Prevent Pandemic Influenza - United States, 2017 | MMWR
Table - Outbreak of Imported Seventh Pandemic Vibrio cholerae O1 El Tor, Algeria, 2018 - Volume 28, Number 6-June 2022 -...
Assessment of genetic diversity and identification of SSR markers associated with grain iron content in Iranian prevalent wheat...
eCite - Genetic Variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF Genes Are Prognostic Markers of Prostate Cancer-Specific...
Markers of kidney function, genetic variation related to cognitive function, and cognitive performance in the UK Biobank | BMC...
Evaluation of genetic similarity between accessions of Pityrocarpa moniliformis (angico-de-bezerro) using RAPD markers | GMR |...
Genetic diversity analysis of Jatropha curcas L. accessions cultivated in Taiwan using inter simple sequence repeats (ISSR)...
Cross-species testing of nuclear markers in Pelophylax water frogs in Greece and examination of their power to detect genetic...
Exploring genetic variation among Jordanian Solanum lycopersicon L. landraces and their performance under salt stress using SSR...
Assessment of genetic diversity revealed by morphological traits and ISSR markers in hazelnut germplasm (Corylus avellana L.)...
Instantaneous Clearing of Biofilm (iCBiofilm): an optical approach to revisit bacterial and fungal biofilm imaging |...
Genetic Diversity and Relationship of Selected Cultivars of Rice, <em>Oryza sativa</em> L. using Random Amplified Polymorphic...
Microsatellite markers4
- Within our group, we work mostly on SNP (single nucleotide polymorphism) and microsatellite markers, analyzing relationships between different inbred lines (in maize) as well as between different species. (uni-bonn.de)
- To identify microsatellite markers associated with wheat grain iron content,38Iranian prevalent wheat genotypes were assessed using 30 pairs of genomic and EST microsatellite markers. (jpmb-gabit.ir)
- The stepwise regression analysis has been used for estimating the relationship between microsatellite markers and grain iron content. (jpmb-gabit.ir)
- We tested 17 microsatellite markers for cross-species amplification in mainland Pelophylax species distributed in southern Balkans and evaluated their power to successfully detect population/species structure. (figshare.com)
Genes6
- The pdx-4 mutation in Streptomyces venezuelae ISP5230 confers a growth requirement for pyridoxal (pdx) and is a marker for the genetically mapped cluster of genes associated with chloramphenicol biosynthesis. (microbiologyresearch.org)
- GENATLAS : un catalogue de la carte des gènes = a catalogue of mapped genes and other markers / Jean Frézal, Marie-Sophie Baule, Thérèse de Fougerolle. (who.int)
- catalogue of mapped genes and other markers. (who.int)
- Antimicrobial resistance occurs through different mechanisms, which include spontaneous (natural) genetic mutations and horizontal transfer of resistant genes through deoxyribonucleic acid (DNA). (who.int)
- Among the 15 genes chosen for the examine of variety, solely 7 genes (sbp-2, sbp-4, lure, msa-1, msa-2b, msa-2c, Bv80) and the ITS area introduced ample genetic variation for the research of phylogeny. (ja-tec.com)
- Association of Genetic Polymorphisms on Vascular Endothelial Growth Factor and its Receptor Genes with Susceptibility to Coronary Heart Disease. (cdc.gov)
Molecular markers4
- Isoenzymes and molecular markers were used to analyse field isolates of P. falciparum and P. vivax. (who.int)
- Study supports the feasibility of using molecular markers for the identification of recrudescence in P. falciparum from fresh infection. (who.int)
- Use of molecular markers can help to understand the genetic diversity of Babesia bovis. (ja-tec.com)
- Despite this genetic variety noticed into teams, there was not ample info obtainable to affiliate molecular markers with virulence of isolates. (ja-tec.com)
ISSR3
- The level of genetic diversity was estimated in a local population of Colorado potato beetle using ISSR-markers and specific pronotum patterns. (cytgen.com)
- Berezovska O.P., Podolich O.V., Sidorenko A.P. Detection of intrapopulation genetic variation of leptinotarsa decemlineata (say) using issr-markers and phenoforms, Tsitol Genet. (cytgen.com)
- Genetic variations of 78 Jatropha curcas L. accessions representing origin of eight countries, cultivated in two locations in Taiwan were determined using inter simple sequence repeats (ISSR) markers. (gov.tw)
Chromosome1
- We then performed genome-wide mapping of the IL1beta results and found a significant marker (quantitative trait locus) on distal chromosome 7. (cdc.gov)
Germplasm2
- The aim of the study was to evaluate the genetic similarities of ten accessions of P . moniliformis available in the active germplasm collection of Embrapa Meio-Norte, using the RAPD markers to select those most suitable for cultivation and/or plant breeding. (geneticsmr.com)
- The study of genetic diversity in different Jatropha curcas L. accessions cultivated in Taiwan comprises a necessary first step in germplasm evaluation towards improving this plant species. (gov.tw)
Species7
- Molecular genetic markers are a possibility to detect relationships between species, populations, variants or even individuals. (uni-bonn.de)
- IMSEAR at SEARO: Markers for population genetic analysis of human plasmodia species, P. falciparum and P. vivax. (who.int)
- Joshi H. Markers for population genetic analysis of human plasmodia species, P. falciparum and P. vivax. (who.int)
- However, the scarcity of information regarding genetic variability within the species limits its possible exploitation as an animal forage. (geneticsmr.com)
- Using genetic data from populations among species inhabiting contact zones could prove vital in filling these gaps. (figshare.com)
- Finally, a thorough genetic marker discovery pipeline led to the retrieval of 85,189 SNPs and 29,076 microsatellites enriching the available genetic markers for this species. (biomedcentral.com)
- We obtained a nearly complete source of transcriptomic sequence as well as marker information for sharpsnout seabream, laying the ground for understanding the complex process of sex differentiation of this economically valuable species. (biomedcentral.com)
Isolates2
- Present report deals with the genetic diversity existing among the field isolates of Plasmodium falciparum and P. vivax in India. (who.int)
- With a WGS file upload and a few clicks of a mouse, public health scientists are minutes away from an easy-to-read report that summarizes information about the isolates in question, including sequence type and genetic mutations associated with reduced antibiotic susceptibility - the information they need to monitor locally circulating strains and to detect emerging resistant gonorrhea and potential transmission clusters. (cdc.gov)
Genetics1
- However, this association may be dependent on the marker of kidney function used, and studies assessing modification by genetics are lacking. (biomedcentral.com)
Populations4
- Under a new theory, modern man's interbreeding with Neanderthals may have left certain populations with a genetic predisposition for contracting COVID in a way that defied initial expectations. (nationalcenter.org)
- Although the grouping was not related to cultivation locations, there was close genetic relationship among the Jatropha populations. (gov.tw)
- Comparison of genetic distances revealed a pattern closer to the Caucasoid population than to the Mongoloid, Oriental or Black populations. (who.int)
- La comparaison des distances génétiques a mis en évidence un schéma plus proche de la population caucasienne que des populations mongoliennes, orientales ou afro-américaines. (who.int)
Microsatellites1
- An other type of commonly used genetic markers are microsatellites. (uni-bonn.de)
Accessions4
- Then, the genetic diversity and relationships within accessions were studied using AFLP markers. (cipotato.org)
- From the accessions used for the agromorphological study, 148 were able to be differentiated by the AFLP markers. (cipotato.org)
- The highest genetic similarity coefficient (0.56) was observed between group I accessions BGFAB6 and BGFAB9 and BGFAB 7 and BGFAB 8, while the lowest coefficient (0.11) was observed between accessions BGFAB3 (group IV) and BGFAB10 (group III). (geneticsmr.com)
- The results revealed that genetic variability is present in the accessions of P . moniliformis . (geneticsmr.com)
Morphological1
- This characterization using both morphological and AFLP markers was realized in order to ultimately build a reliable core collection. (cipotato.org)
Genomic1
- They also created a tool that will allow public health laboratories to analyze their own Ng samples for genomic markers of antimicrobial resistance. (cdc.gov)
Similarity1
- The RAPD data was analyzed to determine the genetic similarity coefficients which ranged from 0.46 to 0.81. (ijcmas.com)
Polymorphisms1
- Single nucleotide polymorphisms (SNPs) are a widely used type of genetic markers. (uni-bonn.de)
Gene2
- The pdx genetic marker adjacent to the chloramphenicol biosynthesis gene cluster in Streptomyces venezuelae ISP5230: functional characterizationThe GenBank accession number for the sequence reported in this paper is AF286159. (microbiologyresearch.org)
- The sequences data of Pattern 1 revealed definitive identity matches in the range of 99% for consensus sequences of S. ellipsospora Kütz, while Pattern 3 indicated definitive identity matches in the range only 93% with S. neglecta Kütz, which DNA sequences of rbcL gene could use as DNA markers of Spirogyra spp. (cmu.ac.th)
Population1
- This is the first population-based study to show that germline genetic variants provide prognostic information for prostate cancer-specific survival. (edu.au)
Traits1
- Being difficult to regenerate and maintain the seeds, the oleaginous bottle gourd was investigated using nine agromorphological traits and 31 amplified fragment length polymorphism (AFLP) markers. (cipotato.org)
Assessment1
- Assessment of genetic diversity revealed. (kayseri.edu.tr)
Genetically1
- This location is close to that of pdxA , the first pdx marker in S. coelicolor A3(2) identified and mapped genetically in Sir David Hopwood's laboratory. (microbiologyresearch.org)
Identification4
- the combination of an abnormal in vitro apoptosis functional test and elevated sFASLs was a predictive marker for ALPS-FAS group identification . (bvsalud.org)
- CMU Intellectual Repository: Molecular Identification, Genetic Relationships and Development of DNA Markers of Spirogyra spp. (cmu.ac.th)
- This study was aimed to investigate the molecular identification, genetic relationships and development of DNA markers of Spirogyra spp. (cmu.ac.th)
- We suggest their future use in genetic studies for the genus Pelophylax in Greece , including the identification of contact zones. (figshare.com)
Occurs1
- The JAK2 genetic marker occurs in more than 95% of PV patients. (cdc.gov)
Analysis2
- Genetic analysis was performed by next-generation sequencing . (bvsalud.org)
- Comparative Transcriptome Analysis Identifying the Different Molecular Genetic Markers Related to Production Performance and Meat Quality in Longissimus Dorsi Tissues of MG × STH and STH Sheep. (ja-tec.com)
Disorders3
- For most genetic disorders, genetic counseling is advised. (medlineplus.gov)
- Many experts believe people with PV and related blood disorders may test positive for the JAK2 marker for a number of years before ever exhibiting symptoms of PV. (cdc.gov)
- Information on HLA antigens can be utilized to assess genetic risk in such disorders. (who.int)
CULTIVARS1
- The genetic diversity in 26 selected cultivars of rice, Oryza sativa L. using 20 decamer random primers. (ijcmas.com)
Chromosomes1
- The chromosomes are made up of strands of genetic information called DNA. (medlineplus.gov)
Study1
- This study evaluated the clinical manifestations, laboratory findings, and molecular genetic results of 215 patients referred as possibly having ALPS. (bvsalud.org)
Possibility1
- A recent JASN paper discusses the possibility of using podocytes captured in the urine for genetic testing. (medscape.com)
Diagnostic1
- Key diagnostic markers for autoimmune lymphoproliferative syndrome with molecular genetic diagnosis. (bvsalud.org)
Females1
- The results also show the difference in the level of genetic diversity of females comparing to males. (cytgen.com)
Content1
- The results of this research can be used in further studies and marker assisted breeding of wheat to increase grain iron content. (jpmb-gabit.ir)
Studies1
- Studies have demonstrated the presence of podocyte protein markers in the urine of women with preeclampsia. (medscape.com)
Data1
- These data help CDC track genetic markers of antibiotic resistance, and this information is then used to develop evidence-based treatment guidelines. (cdc.gov)
Significant1
- The exact test for genotype distribution of the markers showed no significant deviation from the Hardy-Weinberg equilibrium. (nih.gov)
RESOURCES2
- Plant Genetic Resources: Characterization and Utilization. (cipotato.org)
- Apart from the intriguing reproductive biology, it is economically important with a continuously growing aquaculture in the Mediterranean Sea, but limited available genetic resources. (biomedcentral.com)
Evident1
- In an academic paper, Bejan suggested that the homo sapiens who migrated out of Africa and interbred with Neanderthals around 100,000 years ago inherited a genetic predisposition to the coronavirus that is evident now. (nationalcenter.org)
Group1
- A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. (bvsalud.org)
Development1
- To get an overview of the genetic toolkit deployed for the development and maintenance of the differences between sexes, whole-transcriptome approaches are required [ 24 ]. (biomedcentral.com)
Risk2
- Interaction between kidney function markers and a polygenic risk score for general cognitive function was also assessed. (biomedcentral.com)
- Increased urine albumin is associated with worse cognition, but this may depend on genetic risk. (biomedcentral.com)
Environmental2
- of multiple genetic, environmental, and behavioral influences making it possible to measure concentrations of several high- and (7). (cdc.gov)
- of genetic, environmental, and behavioral interactions in adult- exposure to the causal agent and treatment with inhaled glucocorti- onset asthma (8). (cdc.gov)
Years ago1
- With a simple cheek swab, you can learn where your ancestors lived thousands of years ago, as well as which genetic conditions you may be predisposed to later in life. (iflscience.com)
Report1
- The Agency for Toxic Substances and Disease Registry has released its final report regarding the Community Health Screening for the JAK2 genetic marker. (cdc.gov)